0

Journal Articles

in Vaccinations
 61-80 of 568 Articles
From the Centers for Disease Control and Prevention |  January 04, 2012 FREE
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—Advisory Committee on Immunization Practices (ACIP), 2011
JAMA. 2012;307(1):27-28. doi:.
Global Health |  December 21, 2011
Effective Malaria Vaccine
M. J. Friedrich
JAMA. 2011;306(23):2553. doi:10.1001/jama.2011.1808.
Medical News and Perspectives |  December 14, 2011
Outbreaks Spur Measles Vaccine Studies
Tracy Hampton, PhD
JAMA. 2011;306(22):2440-2442. doi:10.1001/jama.2011.1756.
From the Centers for Disease Control and Prevention |  December 14, 2011 FREE
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months—Selected U.S. Regions, 2010-2011
JAMA. 2011;306(22):2449-2452. doi:.
From the Centers for Disease Control and Prevention |  November 23, 2011 FREE
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D)Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
JAMA. 2011;306(20):2211-2212. doi:.
Commentary |  October 19, 2011
Lessons From the US Rotavirus Vaccination Program
Roger I. Glass, MD, PhD; Manish Patel, MD, MSc; Umesh Parashar, MBBS, MPH
JAMA. 2011;306(15):1701-1702. doi:10.1001/jama.2011.1475.
Commentary |  October 19, 2011
Mandatory HPV Vaccination and Political Debate
Lawrence O. Gostin, JD
JAMA. 2011;306(15):1699-1700. doi:10.1001/jama.2011.1525.
From the Centers for Disease Control and Prevention |  October 05, 2011 FREE
National and State Vaccination Coverage Among Children Aged 19-35 Months—United States, 2010
JAMA. 2011;306(13):1434-1437. doi:.
Health Agencies Update |  September 28, 2011
Toddler Flu Vaccinations
Bridget M. Kuehn
JAMA. 2011;306(12):1315. doi:10.1001/jama.2011.1376.
Commentary |  September 21, 2011
The FDA—A Misunderstood Agency
Joshua M. Sharfstein, MD
JAMA. 2011;306(11):1250-1251. doi:10.1001/jama.2011.1345.
From the Centers for Disease Control and Prevention |  September 21, 2011 FREE
Vaccination Coverage Among Children in Kindergarten—United States, 2009-10 School Year
JAMA. 2011;306(11):1196-1198. doi:.
From the Centers for Disease Control and Prevention |  August 03, 2011 FREE
Ten Great Public Health Achievements—Worldwide, 2001-2010
JAMA. 2011;306(5):484-487. doi:.
Medical News and Perspectives |  July 06, 2011
Research Aims to Boost Pertussis Control
M. J. Friedrich
JAMA. 2011;306(1):27-29. doi:10.1001/jama.2011.888.
From the Centers for Disease Control and Prevention |  July 06, 2011 FREE
Ten Great Public Health Achievements—United States, 2001-2010
JAMA. 2011;306(1):36-38. doi:.
From the Centers for Disease Control and Prevention |  May 25, 2011 FREE
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years—United States, 2011
JAMA. 2011;305(20):2062. doi:.
Commentary |  May 11, 2011
Vaccine Liability in the Supreme Court:  Forging a Social Compact
John D. Kraemer, JD, MPH; Lawrence O. Gostin, JD
JAMA. 2011;305(18):1900-1901. doi:10.1001/jama.2011.615.
Medical News & Perspectives |  April 20, 2011
FDA Expands Age Range for Shingles Vaccine
Rebecca Voelker
JAMA. 2011;305(15):1526. doi:10.1001/jama.2011.495.
Medical News & Perspectives |  April 13, 2011
10-Year National Vaccine Plan Aims to Harness New Technology, Enhance Safety
Bridget M. Kuehn
JAMA. 2011;305(14):1399-1400. doi:10.1001/jama.2011.435.
Original Contribution |  April 13, 2011 FREE
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1:  A Randomized Controlled Trial
Odile Launay, MD, PhD; Diane van der Vliet, MD; Arielle R. Rosenberg, MD, PhD; et al.
JAMA. 2011;305(14):1432-1440. doi:10.1001/jama.2011.351.
INCLUDES: , Supplemental Content
Original Contribution |  April 13, 2011 FREE
Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam:  A Cluster Randomized Noninferiority Trial
Kathleen M. Neuzil, MD, MPH; Do Gia Canh, MD; Vu Dinh Thiem, MD; et al.
JAMA. 2011;305(14):1424-1431. doi:10.1001/jama.2011.407.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Observation  |  May 8, 2013
Anti–Laminin-332 Mucous Membrane Pemphigoid Developing After a Diphtheria Tetanus Vaccination
Tanya Sezin, MSc; Ella Egozi, MD; Wissam Hillou, MD; et al.
JAMA Neurology
Viewpoint  |  April 29, 2013
DNA Aβ42 Vaccination as Possible Alternative Immunotherapy for Alzheimer Disease
Roger N. Rosenberg, MD; Doris Lambracht-Washington, PhD
JAMA Internal Medicine
Special Article  |  March 18, 2013
Influenza Vaccines:  Time for a Rethink
Peter Doshi, PhD
JAMA Dermatology
Correspondence  |  Mar 2013
Complete Resolution of Chronic Multiple Verruca Vulgaris Treated With Quadrivalent Human Papillomavirus Vaccine
Benjamin S. Daniel, BA, BCom, MBBS; Dedee F. Murrell, BMBCh, MD, FACD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems